Telcatan Plus Tablet 40/12.5 mg

Adult dose

For patients whose blood pressure is not adequately controlled by telmisartan alone, it should be taken once daily with water, irrespective of meals. Before switching to this combination product, it is recommended to adjust dosages of each component individually as needed. If clinically appropriate, switching directly from monotherapy to this combination product may be considered. - Telmisartan/Hydrochlorothiazide combination 40/12.5 mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40 mg. - Telmisartan/Hydrochlorothiazide combination 80/12.5 mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80 mg. - Telmisartan/Hydrochlorothiazide combination 80/25 mg may be administered to patients whose blood pressure is not adequately controlled with the combination or single-agent treatment of telmisartan 80 mg and hydrochlorothiazide 12.5 mg. Sodium depletion or volume depletion should be corrected before starting treatment with this medication. Patients with Renal Impairment For patients with mild to moderate renal impairment, dose adjustment is not necessary. This medication should not be given to patients with severe renal impairment (creatinine clearance <30 mL/min). Regular monitoring of kidney function is recommended. Patients with Hepatic Impairment For patients with mild to moderate hepatic impairment, this medication should be administered with caution. It should not be given in doses exceeding 40/12.5 mg daily. This medication should not be used in patients with severe hepatic impairment (refer to usage precautions 2). Thiazide diuretics should be used with caution in patients with liver dysfunction. Elderly Patients No dose adjustment is necessary. Children The safety and efficacy of this medication have not been established in patients under 18 years old.

Child dose

The safety and efficacy of this medication have not been established in patients under 18 years old.

This medication can pose serious risks to the fetus, especially during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, use should be discontinued immediately. This medication should not be taken by individuals who have an allergy to its components or certain liver or kidney diseases. Elderly patients or those with elevated potassium levels or impaired liver function should take it with caution, and careful use is necessary in those with heart or vascular diseases. The hydrochlorothiazide component may increase the risk of skin cancer, so sun exposure should be avoided, and skin condition should be monitored regularly. During the use of this medication, side effects such as dizziness, low blood pressure, and electrolyte imbalance may occur, so if symptoms are severe, immediate consultation with healthcare professionals is necessary. It may interact with other antihypertensive medications, diuretics, lithium, and certain antiarrhythmics, so it is essential to inform the doctor about any other medications being taken. Pregnant or breastfeeding women should not take this medication, and if pregnancy is planned, switching to another safe alternative medication is recommended. In case of overdose, symptoms such as low blood pressure, electrolyte abnormalities, and dehydration may occur, so it is crucial to visit a hospital immediately for appropriate measures. This medication is not recommended for children under 18, as its safety and efficacy have not been established.

Serious side effects

Hives, angioedema (including life-threatening outcomes), severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash accompanied by high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reaction, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, jaundice, and extreme lethargy.

Mild side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disturbances, dizziness, visual disturbances, blurred vision, lightheadedness, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, respiratory distress, pulmonary inflammation, pulmonary edema, diarrhea, dry mouth, abdominal distension, abdominal pain, constipation, dyspepsia, vomiting, abnormal liver function/hepatic impairment, angioedema, erythema, pruritus, rash, hyperhidrosis,

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is important to maintain a storage temperature between 1°C and 30°C. Storing it this way helps maintain the effectiveness of the medication.

Appearance

An oval-shaped tablet consisting of two layers, white and pink, with possible pink speckles on the white layer.

Package unit

30 tablets (10 tablets/PTP*3)/box